← Leaderboards
Marco Colonna
Washington University
$45,277,211
Attributed
$61,486,460
Total exposure
34
Grants
30
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.9M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$61,486,460 · 34
By mechanism
R01$31,010,067 · 15
U01$9,782,111 · 1
RF1$6,138,540 · 2
T32$5,565,471 · 2
R21$3,707,188 · 9
P01$2,390,505 · 2
Top collaborators
- Scott J Hultgren13 shared
- Eugene M. Oltz9 shared
- Shabaana A. Khader8 shared
- Clay F. Semenkovich6 shared
- Gary Andrew Weisman5 shared
- Alessandra B Pernis4 shared
- Maria Sara Remedi1 shared
Most similar at Washington University
Same institution · by research overlap
- Alessandra B Pernis$15,040,503
- Vincent Peng$106,392
- Erica G Schmitt$389,412
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseCellsAlzheimer&AposImmuneCytokineSignal TransductionMediatingImmune ResponseReceptorInflammationBaseInfectionInflammatoryMouse ModelPathway InteractionsBacteriaRegulationPlayImmune SystemGenesExperimental StudyInterleukin-22Lymphoid CellIn Vitro
Grant awards (115)
Diabetes and Related Metabolic Diseases$1,002,952
T32 · FY2025 · DK
Spontaneous and Induced B cell and T cell responses in Alzheimer's Disease$759,744
R01 · FY2025 · AG · contact PI
Cis-Regulatory Circuits for ILC Function and Plasticity$750,844
R01 · FY2025 · AI · contact PI
Mucosal Immune Defense Mechanisms of the Urinary Bladder$619,518
R01 · FY2025 · DK · contact PI
The protein tyrosine kinase SYK drives innate immune responses against Alzheimer's Disease$583,197
P01 · FY2025 · AG · contact PI
Ontogenetic niche of B cells at the CNS borders in homeostasis, aging and autoimmunity$561,061
R01 · FY2025 · AI · contact PI
TREM2 IN MICROGLIA BIOLOGY AND ALZHEIMER'S DISEASE$522,816
R01 · FY2025 · AG · contact PI
Targeting TREM2 to boost anti-cancer therapy$441,087
R01 · FY2025 · CA · contact PI
Diabetes and Related Metabolic Diseases$1,010,582
T32 · FY2024 · DK
Spontaneous and Induced B cell and T cell responses in Alzheimer's Disease$775,250
R01 · FY2024 · AG · contact PI
The protein tyrosine kinase SYK drives innate immune responses against Alzheimer's Disease$597,199
P01 · FY2024 · AG · contact PI
Mucosal Immune Defense Mechanisms of the Urinary Bladder$594,739
R01 · FY2024 · DK · contact PI
Ontogenetic niche of B cells at the CNS borders in homeostasis, aging and autoimmunity$587,914
R01 · FY2024 · AI · contact PI
TREM2 IN MICROGLIA BIOLOGY AND ALZHEIMER'S DISEASE$533,486
R01 · FY2024 · AG · contact PI
Elucidating the mechanisms by which microgliopathy causes early-onset dementia$427,625
R21 · FY2024 · AG · contact PI
Targeting TREM2 to boost anti-cancer therapy$419,032
R01 · FY2024 · CA · contact PI
ILT3 (LILRB4) in anti-tumor immunity and immunotherapy$391,277
R21 · FY2024 · CA · contact PI
MICROBIOTA-DEPENDENT CONTROL OF CLOSTRIDIUM DIFFICILE: THE ROLE OF ACETATE AND IL-22 BINDING PROTEIN$389,093
R01 · FY2024 · DK · contact PI
Diabetes and Related Metabolic Diseases$839,889
T32 · FY2023 · DK
Mucosal Immune Defense Mechanisms of the Urinary Bladder$622,838
R01 · FY2023 · DK · contact PI
Ontogenetic niche of B cells at the CNS borders in homeostasis, aging and autoimmunity$598,906
R01 · FY2023 · AI · contact PI
The protein tyrosine kinase SYK drives innate immune responses against Alzheimer's Disease$597,199
P01 · FY2023 · AG · contact PI
Targeting TREM2 to boost anti-cancer therapy$432,265
R01 · FY2023 · CA · contact PI
MICROBIOTA-DEPENDENT CONTROL OF CLOSTRIDIUM DIFFICILE: THE ROLE OF ACETATE AND IL-22 BINDING PROTEIN$410,302
R01 · FY2023 · DK · contact PI
Plasticity of Innate Lymphoid Cells: Mechanisms and Biological Impact$354,375
R01 · FY2023 · DK · contact PI
Impact of Airway Epithelium on Innate and Adaptive Immunity in the Lung$280,005
U19 · FY2023 · AI · contact PI
Impact of polyamines on ILC3 function at steady state and in preclinical model of colitis$233,750
R21 · FY2023 · AI · contact PI
Diabetes and Related Metabolic Diseases$773,856
T32 · FY2022 · DK
CIS-REGULATORY CIRCUITS FOR ILC FUNCTION AND PLASTICITY$639,023
R01 · FY2022 · AI · contact PI
Ontogenetic niche of B cells at the CNS borders in homeostasis, aging and autoimmunity$624,511
R01 · FY2022 · AI · contact PI
The protein tyrosine kinase SYK drives innate immune responses against Alzheimer's Disease$612,910
P01 · FY2022 · AG · contact PI
Targeting TREM2 to boost anti-cancer therapy$432,265
R01 · FY2022 · CA · contact PI
Soluble TREM2 regulation of microglial function in Alzheimer disease$430,625
R21 · FY2022 · AG · contact PI
MICROBIOTA-DEPENDENT CONTROL OF CLOSTRIDIUM DIFFICILE: THE ROLE OF ACETATE AND IL-22 BINDING PROTEIN$415,111
R01 · FY2022 · DK · contact PI
Plasticity of Innate Lymphoid Cells: Mechanisms and Biological Impact$354,375
R01 · FY2022 · DK · contact PI
Impact of Airway Epithelium on Innate and Adaptive Immunity in the Lung$333,929
U19 · FY2022 · AI · contact PI
Impact of polyamines on ILC3 function at steady state and in preclinical model of colitis$196,875
R21 · FY2022 · AI · contact PI
TREM2 IN MICROGLIA BIOLOGY AND ALZHEIMER'S DISEASE$1,621,044
RF1 · FY2021 · AG · contact PI
Diabetes and Related Metabolic Diseases$772,867
T32 · FY2021 · DK
The role of TGFbeta in development and function of salivary gland innate lymphoid cells$683,136
R01 · FY2021 · DE · contact PI
The Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis$674,402
R01 · FY2021 · AI
CIS-REGULATORY CIRCUITS FOR ILC FUNCTION AND PLASTICITY$650,048
R01 · FY2021 · AI · contact PI
MICROBIOTA-DEPENDENT CONTROL OF CLOSTRIDIUM DIFFICILE: THE ROLE OF ACETATE AND IL-22 BINDING PROTEIN$434,135
R01 · FY2021 · DK · contact PI
Targeting TREM2 to boost anti-cancer therapy$416,242
R01 · FY2021 · CA · contact PI
Impact of Airway Epithelium on Innate and Adaptive Immunity in the Lung$371,575
U19 · FY2021 · AI · contact PI
Plasticity of Innate Lymphoid Cells: Mechanisms and Biological Impact$354,375
R01 · FY2021 · DK · contact PI
The Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis$241,329
R01 · FY2021 · AI
Mucosal Immune Defense Mechanisms of the Urinary Bladder$1,460,729
U01 · FY2020 · AI · contact PI
The role of TGFbeta in development and function of salivary gland innate lymphoid cells$690,742
R01 · FY2020 · DE · contact PI
Diabetes and Related Metabolic Diseases$690,126
T32 · FY2020 · DK
The Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis$674,402
R01 · FY2020 · AI
CIS-REGULATORY CIRCUITS FOR ILC FUNCTION AND PLASTICITY$650,048
R01 · FY2020 · AI · contact PI
Impact of Airway Epithelium on Innate and Adaptive Immunity in the Lung$469,221
U19 · FY2020 · AI · contact PI
The Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis$358,637
R01 · FY2020 · AI
Plasticity of Innate Lymphoid Cells: Mechanisms and Biological Impact$354,095
R01 · FY2020 · DK · contact PI
The Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis$117,308
R01 · FY2020 · AI
THERAPEUTIC STRATEGIES FOR ALZHEIMER'S DISEASE BASED ON TREM2 BIOLOGY$2,611,246
RF1 · FY2019 · AG · contact PI
Mucosal Immune Defense Mechanisms of the Urinary Bladder$1,548,815
U01 · FY2019 · AI · contact PI
The role of TGFbeta in development and function of salivary gland innate lymphoid cells$697,985
R01 · FY2019 · DE · contact PI
CIS-REGULATORY CIRCUITS FOR ILC FUNCTION AND PLASTICITY$686,003
R01 · FY2019 · AI · contact PI
The Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis$674,402
R01 · FY2019 · AI
Impact of Airway Epithelium on Innate and Adaptive Immunity in the Lung$435,174
U19 · FY2019 · AI · contact PI
IMPACT OF NOVEL REGULATORS OF TREM2 EXPRESSION ON ALZHEIMER'S DISEASE$228,750
R21 · FY2019 · AG · contact PI
Mucosal Immune Defense Mechanisms of the Urinary Bladder$2,330,854
U01 · FY2018 · AI · contact PI
The Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis$976,790
R01 · FY2018 · AI
The role of TGFbeta in development and function of salivary gland innate lymphoid cells$705,229
R01 · FY2018 · DE · contact PI
CIS-REGULATORY CIRCUITS FOR ILC FUNCTION AND PLASTICITY$654,900
R01 · FY2018 · AI · contact PI
CRTAM-CADM1 INTERACTION IN THE BIOLOGY OF GUT LYMPHOCYTES$343,125
R01 · FY2018 · DK · contact PI
IMPACT OF NOVEL REGULATORS OF TREM2 EXPRESSION ON ALZHEIMER'S DISEASE$190,625
R21 · FY2018 · AG · contact PI
Mucosal Immune Defense Mechanisms of the Urinary Bladder$1,667,884
U01 · FY2017 · AI · contact PI
The role of TGFbeta in development and function of salivary gland innate lymphoid cells$723,481
R01 · FY2017 · DE · contact PI
The Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis$712,802
R01 · FY2017 · AI
Cis-Regulatory Circuits for ILC Function and Plasticity$621,424
R56 · FY2017 · AI
CRTAM-CADM1 INTERACTION IN THE BIOLOGY OF GUT LYMPHOCYTES$343,125
R01 · FY2017 · DK · contact PI
Mucosal Immune Defense Mechanisms of the Urinary Bladder$926,653
U01 · FY2016 · AI · contact PI
CRTAM-CADM1 INTERACTION IN THE BIOLOGY OF GUT LYMPHOCYTES$343,125
R01 · FY2016 · DK · contact PI
CHROMATIN-BASED DISCOVERY OF ILC GENE REGULATORY CIRCUITS$190,625
R21 · FY2016 · AI
TREM2 IN MICROGLIA BIOLOGY AND ALZHEIMER'S DISEASE$1,906,250
RF1 · FY2015 · AG · contact PI
INHIBITORY RECEPTORS IN IMMUNITY AGAINST LETHAL ACUTE VIRUS INFECTION$381,250
R56 · FY2015 · AI · contact PI
Mucosal Immune Defense Mechanisms of the Urinary Bladder$353,398
U01 · FY2015 · AI · contact PI
CRTAM-CADM1 INTERACTION IN THE BIOLOGY OF GUT LYMPHOCYTES$343,125
R01 · FY2015 · DK · contact PI
CHROMATIN-BASED DISCOVERY OF ILC GENE REGULATORY CIRCUITS$228,750
R21 · FY2015 · AI
THE ROLE OF NK-22 CELLS IN ANTI-HIV-1 MUCOSAL IMMUNITY$361,152
R01 · FY2014 · DE · contact PI
Mucosal Immune Defense Mechanisms of the Urinary Bladder$353,780
U01 · FY2014 · AI · contact PI
THE ROLE OF IL-34 IN THE BIOLOGY OF LANGERHANS CELLS$228,000
R21 · FY2014 · AI · contact PI
CONTROLLING NK CELL ANTI-CANCER ACTIVITY: THE ROLE OF NUTRIENTS AND SUPPLEMENTS$192,409
R21 · FY2014 · CA · contact PI
Cell Biologic approaches to Diabetes Research$171,196
T32 · FY2014 · DK · contact PI
THE ROLE OF NK-22 CELLS IN ANTI-HIV-1 MUCOSAL IMMUNITY$103,776
R01 · FY2014 · DE · contact PI
Cell Biologic approaches to Diabetes Research$58,625
T32 · FY2014 · DK · contact PI
Mucosal Immune Defense Mechanisms of the Urinary Bladder$425,218
U01 · FY2013 · AI · contact PI
THE ROLE OF NK-22 CELLS IN ANTI-HIV-1 MUCOSAL IMMUNITY$346,706
R01 · FY2013 · DE · contact PI
Cell Biologic approaches to Diabetes Research$191,147
T32 · FY2013 · DK · contact PI
THE ROLE OF IL-34 IN THE BIOLOGY OF LANGERHANS CELLS$190,000
R21 · FY2013 · AI · contact PI
CONTROLLING NK CELL ANTI-CANCER ACTIVITY: THE ROLE OF NUTRIENTS AND SUPPLEMENTS$165,300
R21 · FY2013 · CA · contact PI
Cell Biologic approaches to Diabetes Research$54,231
T32 · FY2013 · DK · contact PI
THE ROLE OF NK-22 CELLS IN ANTI-HIV-1 MUCOSAL IMMUNITY$361,152
R01 · FY2012 · DE · contact PI
Mucosal Immune Defense Mechanisms of the Urinary Bladder$353,780
U01 · FY2012 · AI · contact PI
Mucosal Immune Defense Mechanisms of the Urinary Bladder$361,000
U01 · FY2011 · AI · contact PI
THE ROLE OF NK-22 CELLS IN ANTI-HIV-1 MUCOSAL IMMUNITY$353,856
R01 · FY2011 · DE · contact PI
THE ROLE OF NK-22 CELLS IN ANTI-HIV-1 MUCOSAL IMMUNITY$364,800
R01 · FY2010 · DE · contact PI
The Functional of TREM-1 in Sepsis$285,912
R01 · FY2010 · GM · contact PI
The Functional of TREM-1 in Sepsis$288,800
R01 · FY2009 · GM · contact PI
The Functional of TREM-1 in Sepsis$288,800
R01 · FY2008 · GM · contact PI
Plasmacytoid Dendritic Cells in Anti-Tumor Response$227,715
R01 · FY2008 · CA · contact PI
Immune Defense: The Role of NKG2D/DAP10$362,679
R01 · FY2007 · AI · contact PI
The Functional of TREM-1 in Sepsis$288,800
R01 · FY2007 · GM · contact PI
Plasmacytoid Dendritic Cells in Anti-Tumor Response$227,715
R01 · FY2007 · CA · contact PI
Nectins in Tumor Immunosurveillance$221,692
R21 · FY2007 · AI · contact PI
Immune Defense: The Role of NKG2D/DAP10$373,511
R01 · FY2006 · AI · contact PI
Plasmacytoid Dendritic Cells in Anti-Tumor Response$235,288
R01 · FY2006 · CA · contact PI
Nectins in Tumor Immunosurveillance$190,885
R21 · FY2006 · AI · contact PI
Immune Defense: The Role of NKG2D/DAP10$382,500
R01 · FY2005 · AI
Plasmacytoid Dendritic Cells in Anti-Tumor Response$241,609
R01 · FY2005 · CA
Immune Defense: The Role of NKG2D/DAP10$382,500
R01 · FY2004 · AI
Immune Defense: The Role of NKG2D/DAP10$191,250
R01 · FY2003 · AI